Molekule Group, Inc.

Molekule Group manufactures FDA-cleared Class II medical device air purifiers for residential indoor air quality improvement. The company's flagship technology is PECO (Photoelectrochemical Oxidation), a proprietary catalyst-coated media that uses light and free radicals to oxidize and destroy airborne pollutants at the molecular level, complemented by HEPA filtration (99.97% capture of particles ≥0.3 microns) and activated carbon layers. Product line includes the Air Pro (up to 1,000 sq ft coverage) and Air Mini+ (up to 250 sq ft), both equipped with real-time air quality sensors and smartphone app integration for indoor/outdoor pollutant monitoring. Independent third-party testing (Intertek, Aerosol Research and Engineering Labs) demonstrates efficacy against smoke (99% removal in 22 min), black mold spores (99.993% reduction in 1 hr), pollen (99% removal in 10 min), dust, viruses (MS2 99.998% removal), bacteria (E. coli, Bacillus), and volatile organic compounds (formaldehyde, toluene, d-limonene). Devices are FSA/HSA-eligible and marketed for residential use with emphasis on allergy relief, mold control, wildfire smoke mitigation, pet dander removal, and virus destruction. Company provides filter subscription services and operates a direct-to-consumer e-commerce model with mobile app ecosystem for air quality tracking.